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Abstract
The four residues at the amino-terminus of mature Smac/DIABLO are an IAP binding motif (IBM). Upon exit from
mitochondria, mature Smac interacts with inhibitor of apoptosis proteins (IAPs), abrogating caspase inhibition. We used the
ubiquitin fusion model to express mature Smac in the cytosol. Transiently expressed mature Smac56-239 (called Smac56)
and Smac60-239 (called Smac60), which lacks the IBM, interacted with X-linked inhibitor of apoptosis protein (XIAP).
However, stable expression produced wild type Smac56 that failed to homodimerize, interact with XIAP, and potentiate
caspase activation. Cytosolic Smac60 retained these functions. Cytosolic Smac56 apparently becomes posttranslationally
modified at the dimer interface region, which obliterated the epitope for a monoclonal antibody. Cytosolic Smacd, which
has the IBM but lacks amino acids 62–105, homodimerized and weakly interacted with XIAP, but failed to potentiate
apoptosis. These findings suggest that the IBM of Smac is a recognition point for a posttranslational modification(s) that
blocks homodimerization and IAP interaction, and that amino acids 62–105 are required for the proapoptotic function of
Smac.
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Introduction
Human Smac/DIABLO is a cytoplasmically translated protein
composed of 239 amino acids, the first 55 of which are required
for mitochondrial import [1,2]. The Smac gene consists of seven
exons that can produce four isoforms: wild type Smac, Smacb,
Smacc, and Smacd [3,4]. Wild type Smac lacks exon 2. Smacb
lacks exons 1 and 3, and translation of b initiates at an alternative
start codon within exon 2, rendering it incompetent for
mitochondrial translocation. Smacc lacks exons 2 and 3, while
Smacd lacks exons 2 and 4. Upon translocation to the
mitochondrial intermembrane space, an inner membrane pepti-
dase complex removes the first 55 amino acids to produce mature
Smac56 (Smac56-239) [5]. The first four amino acids of mature
Smac (A
56VPI
59) are an IBM, which complexes with the BIR3
(baculovirus IAP repeat) domain of X-linked IAP (XIAP) [6,7].
Homologous IBM sequences occur in Drosophila mitochondrial
proteins Grim, Reaper, and Hid [7], the mitochondrial serine
protease Omi/HtrA2 [8], and the p12 subunit of caspase-9 [9].
Structural studies of Smac complexed with the third BIR domain
of XIAP suggested that the IBM may be essential for the
interaction with IAPs [6,10].
The Smac monomer is a double hairpin bundle of three a-
helices [6]. Purified recombinant mature Smac forms an
extraordinarily stable homodimer (half-life ,20,000 years) [11].
The predominantly hydrophobic dimer interface forms an
antiparallel four-helix bundle which has an arch shape [6]. The
IBM of each Smac protomer can simultaneously interact with the
second and third BIR domains of a single XIAP molecule [12].
Specific amino acid substitutions within the hydrophobic interface,
such as F88D (also called F33D by subtraction of the first 55
residues), prevent Smac homodimerization [6]. The aforemen-
tioned Grim and Reaper have a GH3-like amphipathic helix,
which is crucial to a proapoptotic function that is independent of
IAP antagonism [13,14]. Smacb (also called Smac-S) and a
truncated Smac76-239 mutant, both of which lack the IBM and
localize to the cytosol, potentiated apoptosis evoked by chemo-
therapeutic agents [3,15]. Importantly Smacb, but not the
truncated Smac76-239 mutant, complexed with XIAP, cIAP1,
and cIAP2. While the IBM of Smac is not essential for the
interaction with the IAPs, the segment close to the amino-terminus
of mature Smac is necessary for IAP interaction [3].
There are eight human IAP family members, each of which has
at least one BIR domain. The BIR domain, which is the defining
feature of IAPs, is responsible for binding caspases. BIR2 and
BIR3 of XIAP directly bind and inhibit processed capase-3 and
processed caspase-9, respectively [reviewed in [16,17]]. While
XIAP binds and inhibits caspases, other IAPs seem not to directly
inhibit the catalytic activity of caspases [17]. However, cIAP1 can
potently prevent caspase-9 activation of procaspase-3 via interac-
tion with the IBM of the p12 subunit of processed caspase-9 [18].
In addition to three BIR domains, XIAP has a RING domain with
ubiquitin (Ub) ligase activity. Livin (also called ML-IAP) has a
single BIR of the BIR3 type and a RING domain [19]. Survivin,
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which may not bind IBMs [19]. cIAPs 1 and 2, have a CARD
domain, which mediates protein interactions, three BIRs, and a
RING domain. Apollon/BRUCE, the largest of the IAPs, has a
single N-terminal BIR domain and a UBC (Ub conjugation
domain) at the C-terminus [20]. The two remaining IAPs, testis
specific IAP (Ts-IAP) and neuronal apoptosis inhibitory protein
(NAIP), were not included in the present study. Transcripts of all
the IAPs, except Ts-IAP and NAIP, were detected by RT-PCR in
the cell model used here, namely the 911 line of human embryonic
retinoblasts (A. D. Steg and M. R. Johnson, unpublished data,
University of Alabama at Birmingham).
IAPs with a RING domain dock an E2 Ub conjugating enzyme
and a target protein that accepts Ub, which constitutes an E3 Ub
ligase [21,22,23]. cIAPs 1 and 2, Livin, and XIAP catalyze
transubiquitination of substrate proteins, such as cytosolic mature
Smac and caspases [24,25,26]. The converse can also occur, for
example, Smac can selectively reduce the levels of cIAP1 and 2 by
promoting their autoubiquitination [27]. Besides transubiquitinat-
ing substrate proteins, XIAP also is subject to autoubiquitination
[28]. Although Apollon lacks a RING domain, it uses an E2 Ub
conjugation domain to ubiquitinate Smac and caspase-9 [29].
Grim and Reaper, which are functional homologs of Smac, can
stimulate autoubiquitination of XIAP [30,31]. Coexpression of
ectopic Smacd and XIAP decreased the cellular level of endo-
genous XIAP [4]. cIAPs play important roles in the regulation of
tumor necrosis factor alpha (TNFa)-mediated NF-kB activation
[32,33,34]. cIAPs are multifunction E3 Ub ligases which can
polyubiquitinate target proteins via Lys-48 or Lys-63 of Ub. The
latter serves a nondegradative function. For example, by addition
of a Lys-63-linked polyubiquitin chain to RIP1, cIAPs influence
TNFa -induced NF-kB activation [35,36]. IAPs clearly regulate
apoptosis by multiple mechanisms, which are subject to modula-
tion by Smac.
In this study, we used the Ub fusion model to determine
whether wild type mature Smac maintains a proapoptotic function
after prolonged cytosolic localization, and evaluate the require-
ment of the IBM to induce apoptosis [37,38,39]. We show that
stable cytosolic expression of Smac56 attenuates homodimeriza-
tion and Smac’s ability to bind IAPs, which are considered critical
for the proapoptotic function of Smac. The present study has
uncovered a novel mechanism of Smac downregulation, which is
distinct from protein disassembly by the Ub proteasome system.
Results
Ub fusion produces mature Smac in the cytosol after
stable or transient transfection
Mammalian cells have the highly specific protease, ubiquitin C-
terminal hydrolase (UCH), which cotranslationally cleaves the
nascent polyubiquitin protein between Gly 76 of one Ub and the
initial Met of the next Ub or removes Ub when it is fused to the
amino-terminal residue of another protein [37,38]. Smac
1-239-V5
and Ub-Smac56-V5 fusion constructs were stably or transiently
expressed in 911 cells. Western blot analysis of mitochondrial and
cytosol fractions, confirmed cytosolic expression of Smac56-V5
following stable or transient expression (Fig. 1 A, lanes 2 and 3). In
contrast, ectopic expression of full-length Smac
1-239-V5, which has
the mitochondrial localization sequence (the first 55 residues),
produced mature Smac56-V5 that was predominantly in the
mitochondrial pellet (Fig. 1A, lane 4). The minor amount of
transient Smac56-V5 from the Ub fusion protein in the
mitochondrial fraction was likely due to slight contamination with
cytosol (Fig. 1A, lane 3).
Interaction of transiently expressed Smac variants with
XIAP
911 cells were transiently cotransfected with GST-XIAP and
wild type or a variant of Ub-Smac-V5 in order to evaluate the
ability of Smac to interact with XIAP. GST-XIAP pulled down
wild type Smac56 and Smac60, which lacks the IBM. The
pulldown of Smac60 was slightly less efficient than the pulldown of
wild type Smac56-V5 (Fig. 1B, lanes 4 and 5). Smacd-V5, which
has the IBM but lacks amino acids 62 to 105, was scarcely
detectable in the GST-XIAP pulldown by comparison to the
pulldown of Smac56-V5 or Smac60-V5 (Fig. 1B, lane 6). These
results indicate that the IBM of Smac is neither sufficient, nor
necessary, for interaction with XIAP, as reported previously [3,6].
There was no detectable Smac pulled down from cells that were
transfected only with Ub-Smac56-V5 or Smac60-V5, which
confirmed the requirement for GST-XIAP (Fig. 1B, lane 1 and 2).
Homo- and hetero-dimerization of transiently expressed
wild type Smac56 and Smacd
Pulldown experiments were done with lysates from cells that
transiently coexpressed ectopic Ub-Smac56 or Ub-Smacd with a C-
terminal GST tag and wild type Ub-Smac56 or a Ub-Smac variant
with a C-terminal V5 tag. Smac56-GST interacted strongly with
Smac56-V5 and with Smac60-V5, as indicated by abundance of
Smac-V5 in the pulldown (Fig. 2, lanes 3 and 4). Expression of full-
length Smac
1-239-V5 produced mature Smac56-V5 (Input, anti-V5
panel) as a result of processing within mitochondria and the band of
unprocessed Smac
1-239-V5, which presumably had not yet been
imported by mitochondria (Fig. 2, lane 2). Interestingly, Smac56-
GST pulled down unprocessed full-length Smac
1-239-V5, but the
mitochondrially processed Smac56-V5 was undetectable in the
pulldown (Fig. 2, lane 2). This result suggests that the mitochondrial
Smac56-V5 may be present as a homodimer that is too stable to
exchange with cytosolic Smac-56-GST homodimer during the
experiment. Consistent with the pulldown of full-length Smac
1-239,
Smac56-GSTpulled down unprocessed
G76VUb-Smac56-V5 fusion
protein (Fig. 2, lane 1). Thus, neither the first 55 amino acids of
Smac, nor Ub fused to the amino-terminus of Smac prevented
Smac dimerization. Although Smacd-GST pulled down Smacd-V5,
Smacd-GST failed to pulldown detectable wild type Smac56-V5
(Fig. 2, lanes 5 and 6). Thus, while Smacd homodimerized, it failed
to heterodimerize with wild type Smac56. This result suggests that
the amino acids 62 to 105 of wild type Smac prevent it from
interacting with Smacd.
Cytosolic Smac60 potentiates PARP cleavage and
caspase activation evoked by proteasome blockade
Next we compared the degree of PARP processing evoked by
proteasome blockade in cell lines that expressed cytosolic Ub-
Smac-V5 variants (Smac56, Smac60, and Smacd) or empty vector
(IRES2.eGFP). Western analysis showed that the cell lines
expressed similar levels of wild type and Smac variant proteins
(Fig. 3A). The cells were treated with a potent peptidyl proteasome
inhibitor, zIEALal, for 8 h or were untreated. Faint levels of
cleaved PARP were detectable in untreated cells. Treatment with
zIEALal increased cleaved PARP in lysates of cells that expressed
GFP only (‘‘Mock’’), Smac56-V5, or Smacd-V5 (Fig. 3B, lanes 2,
4, and 8). Surprisingly, Smac60-V5 markedly potentiated the
accumulation of cleaved PARP (Fig. 4B, lanes 5 and 6). Thus,
Smac60, but not wild type or Smacd, potentiated the induction of
apoptosis evoked by proteasome blockade.
Treatment with zIEALal for 18 h increased hydrolysis of
caspase-3 substrate Ac-DEVD-amc to varying extents in lysates
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Smac60, and Smacd) or empty vector (‘‘Mock’’) (Fig. 3C). Smac60
and produced a 7.3 fold potentiation of caspase-3-like activity
evoked by zIEALal. Smac56 and Smacd only modestly increased
caspase-3 like activity (1.7- and 1.5-fold, respectively) relative to
the empty vector (Fig. 3C).
Cytosolic Smac56 and Smac60 potentiate induction of
apoptosis and cell death
Apoptosis and cell death were determined by flow cytometry
analysis of annexin V-PE binding and 7-AAD uptake by cell lines
expressing cytosolic Smac56, 60, and d, after a 24 h zIEALal
treatment (Fig. 4). Stable expression of cytosolic Smac56 and
Smac60, but not Smacd, potentiated the induction of apoptosis
and cell death evoked by zIEALal. Smac56 and Smac60
potentiated the induction of apoptosis by 2.8- and 3.2-fold,
respectively, relative to the cells that expressed only GFP (‘‘Mock’’)
(Fig. 4, ‘‘Apoptotic’’). The much greater potentiation of caspase-3
activation (Fig. 3C), but similar induction of apoptosis by Smac60
compared to wild type Smac56 suggests that caspase activation
may not mediate the proapoptotic action of cytosolic Smac56.
Stably expressed cytosolic Smac56 fails to dimerize or
interact with XIAP
Cell lines that stably expressed cytosolic Smac56-V5, Smac60-
V5, and Smacd-V5 were transiently transfected with Ub-Smac56
or Ub-Smacd with a C-terminal GST tag. The cells were lysed and
proteins were pulled down with GSH agarose to assess the
capacity of Smac to dimerize. Smac56-GST pulled down stably
expressed Smac60-V5, but no Smac56-V5 was detectable in the
pulldown (Fig. 5A, lower panel). Smacd-GST pulled down Smacd-
V5, but to a much smaller extent than the pulldown of Smac60-V5
by Smac56-GST (Fig. 5A). Furthermore the cell lines that stably
expressed Smac56-V5, Smac60-V5, and Smacd-V5 were tran-
siently transfected with GST-XIAP to determine whether the
cytosolic Smac variants interacted with XIAP. Consistent with the
failure of stably expressed Smac56 to dimerize, GST-XIAP failed
to pulldown stably expressed Smac56 (Fig. 5B). GST-XIAP readily
pulled down stably expressed Smac60 and, as previously reported
[4], weakly pulled down Smacd (Fig. 5B). These results indicate
that persistent cytosolic expression of Smac56, severely impairs the
ability of Smac56, but not Smac60, to dimerize and to interact
with XIAP.
Smac56 fails to oligomerize after stable cytosolic
expression
Recombinant Smac forms an elongated dimer, which elutesas an
approximately 100 kDa species by gel filtration chromatography,
while the F88D missense mutant of mature Smac is a 21 kDa
monomer [1,6]. Proteins from cells that transiently or stably
expressed cytosolic Smac56-V5, Smac60-V5, or
F88DSmac56-V5
were fractionated by native or 8 M urea PAGE. Ectopic Smac56-
V5 and Smac60-V5 have a predicted charge of minus 11 at pH 7,
which explains the mobility during native electrophoresis. Under
native conditions, stably expressed Smac56-V5 and
F88DSmac56-
V5 migrated as a single band with essentially the same mobility
(Fig. 6, lanes 1 and 3). Transiently expressed Smac56-V5, like stably
and transiently expressed Smac60-V5, migrated as two bands with
reduced electrophoretic mobility compared to the monomeric
F88DSmac56-V5 mutant (Fig. 6A, lanes 2, 4, and 5). The two Smac
bands with reduced mobility are probably oligomeric species, such
as a dimer and tetramer, because they migrated as a single species in
the presence of 8 M urea and comigrated with monomeric
F88DSmac56-V5 (Fig. 6, bottom). Because Smac migrated as a
single band in the presence of 8 M urea, the two Smac bands
observed by native PAGE chiefly differ in mass, presumably in
quaternary structure, rather than in charge.
On the native gel, the two bands of stably or transiently
expressed Smac60-V5 had a slightly faster mobility than those of
transiently expressed Smac56-V5 (Fig. 6, top). Similarly, Smac60-
V5, which is ,400 Da smaller than Smac56-V5, migrated slightly
faster than wild type Smac56-V5 by SDS-PAGE (Fig. 7A, anti-V5,
lanes 2, 3, 5, and 6). These findings indicate that persistent
expression of wild type Smac56, but not Smac60, in the cytosol of
911 cells essentially abolished its ability to oligomerize. Hence,
persistent cytosolic expression of wild type Smac56, but not
Smac60, predisposes it to a posttranslational modification(s) that
blocks dimer formation without affecting its mobility by SDS-
PAGE (Fig. 7A, anti-V5, lanes 2 and 5) or 8 M urea PAGE
(Fig. 6B, lanes 1 and 4).
Monoclonal Smac antibody fails to detect ectopic wild
type Smac56 after stable cytosolic expression
The following results show that presistent cytosolic expression of
wild type Smac56 essentially abolished immunostaining by a
monoclonal Smac antibody. The antibody failed to immunostain
Smacd, which lacks amino acids 62–105 (Burke and Smith,
unpublished data). The epitope of the Smac antibody was further
localized to a dimer interface region of Smac using Smac mutants
(Fig. 7). Proteins from cells that stably or transiently expressed
cytosolic, V5 tagged Smac56, Smac60, or
F88DSmac56 and
untransfected cell lysates were resolved by SDS-PAGE, and
analyzed by successive western blots with a monoclonal antibody
to Smac or to the V5 tag. The Smac monoclonal antibody
immunostained endogenous mitochondrial Smac56 and transient-
ly expressed Smac56-V5 and Smac60-V5, which migrated
somewhat slower than endogenous wild type Smac56 due to the
presence of the V5 epitope tag (Fig. 7A). The Smac monoclonal
antibody failed to immunostain stably expressed Smac56-V5 or
the following dimeric interface mutants of Smac56: V78E, V81D,
or F88D Smac56-V5 after stable or transient expression (Fig. 7A
and 7B). Similarly the Smac monoclonal failed to recognize the
V78E, V81D, and F88D Smac56 mutants following transient
expression in 911 cells (Burke and Smith, unpublished data). The
Smac antibody immunostained transiently expressed Smac56-V5,
stably or transiently expressed Smac60-V5, and the stably
expressed L163D Smac56 mutant (Fig. 7A and 7B). The L163D
mutant fails to dimerize [6]. Note that there was less ectopic wild
type Smac56 and Smac60 after stable compared to transient
expression (Fig. 7A, lanes 3 and 6, anti-Smac and anti-V5 panels).
Figure 1. Cytosolic expression of mature Smac variants and the interaction of Smac56, Smac60, and Smacd with XIAP following
transient expression. (A) Cells were stably or transiently transfected with IRES2.eGFP expression plasmid (Stable versus Transient) containing Ub-
Smac56 or full-length Smac 1-239. 911 cells were subjected to hypotonic lysis, and cytosol and mitochondrial fractions were prepared by differential
centrifugation. Proteins were resolved by SDS-PAGE and subjected to western blot analysis with a V5 antibody to detect ectopic Smac. (B) Cells were
transiently cotransfected with the indicated GST vector (pGFLEX) and the indicated HA-Ub-Smac (pcDNA3.1-V5His). Two days later cells were lysed,
and proteins were purified using GSH-agarose. Lysate proteins (Input) and proteins eluted from the GSH-agarose (Pulldown) were resolved by SDS-
PAGE and subjected to western blot analysis with antibody to the V5 epitope or XIAP.
doi:10.1371/journal.pone.0013094.g001
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ectopic Smac after transient expression (Fig. 7A, anti-Smac). Thus
the cellular level of ectopic Smac after stable expression was
substantially lower than that of endogenous Smac (Fig. 7A).
Wild type and mutant Smac proteins were similarly immuno-
reactive with the antibody to the V5 tag (Fig. 7A and 7B). These
results suggest that a posttranslational modification(s) at or near
the dimer interface, which includes residues V78 to F88, is
responsible for the loss of immunoreactivity. Smac dimerization
per se does not affect the integrity of the epitope because the
antibody immunostained the L163D mutant (Fig. 7B, anti-Smac).
Furthermore, native PAGE of L163D Smac56 showed that it
migrated as a single band with essentially the same mobility as the
F88D mutant (Burke and Smith, unpublished data).
Figure 2. Transiently expressed Smac56 homodimerizes and heterodimerizes with Smac60, but not with Smacd. Cells were transiently
cotransfected with the Ub-Smac56 or Ub-Smacd with a C-terminal GST tag (pGFLEX) and with full-length Smac
1-239, Ub-Smac56, Ub-Smac60, Ub-
Smacd,o r
G76VUb-Smac56 with a C-terminal V5 tag (pcDNA3.1-HA-Ub-Smac-V5), as indicated. Cells were lysed, and proteins were purified using GSH-
agarose. Lysate proteins (Input) and proteins eluted from the GSH-agarose (Pulldown) were resolved by SDS-PAGE and subjected to western blot
analysis with antibody to GST-pi and to the V5 tag.
doi:10.1371/journal.pone.0013094.g002
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interaction with Apollon and cIAP1 and cIAP2
Finally, we determined whether stable transfection of cytosolic
Smac56-V5 affected the interaction with IAP family members
generally. Anti-V5 co-immunoprecipitations were performed on
lysates from cells that transiently expressed a FLAG-tagged IAP
(Apollon, cIAPs 1 and 2, Livin alpha, Survivin, and XIAP) that
were mixed with cells that transiently or stably expressed Ub-
Smac56-V5. The cell lines that stably expressed wild type Smac56
were treated with zIEALal for 12 h to increase the level of
Smac56-V5 to essentially the same level as that of the transiently
transfected cells (Fig. 8, anti-V5, Input). Transiently expressed
Smac56-V5 pulled down FLAG-tagged Apollon, cIAP1, cIAP2, or
XIAP as indicated by western blot of the co-immunoprecipitates
(Fig. 8, lanes 1, 3, 5, and 11, respectively). By comparison to
transiently expressed Smac56-V5, stably expressed Smac56-V5
very weakly pulled down FLAG-tagged Apollon, cIAP1, cIAP2, or
XIAP (Fig. 8, Lanes 2, 4, 6, and 12 respectively). FLAG-tagged
Livin and Survivin failed to pull down either transiently or stably
expressed Smac56-V5 (Fig. 8, lanes 7–10). The very weak
Figure 3. Persistent cytosolic expression of Smac60, but not Smac56, potentiates activation of caspase-3-like activity by zIEALal. (A)
Cells, which stably expressed the indicated Smac variant in the IRES2.eGFP vector, were lysed and proteins (30 mg) were subjected to western blot
analysis with V5 antibody. (B) Stable Smac cell lines (IRES2.eGFP) were plated, and the following day they were treated for 8 h with 20 mM zIEALal or
left untreated. Cell lysates were subjected to western blot analysis for intact PARP (B, top panel) or PARP cleaved after aspartate 214 (B, middle panel).
Anti b-tubulin western blot confirmed equivalent protein loading (B, bottom panel). (C) Cell lines were treated for 18 h with 20 mM zIEALal or
untreated. Lysates (0.75 mg) were assayed for caspase-3-like activity by continuously recording fluorescence of amc produced by hydrolysis of Ac-
DEVD-amc. Columns indicate mean amc produced 6 S.E.M. Two-way Anova followed by the Bonferroni post-test gave a p value of ,0.001 for zIEALal
treated Smac60 compared to the empty IRES vector (n=4) (Prism 5, Graphpad Software). Mock indicates cell lines stably transfected with empty
vector.
doi:10.1371/journal.pone.0013094.g003
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differs from the previously demonstrated undetectable pulldown of
stably expressed Smac56-V5 by GST-XIAP from untreated cells
(Fig. 5B). We have observed that inhibition of the proteasome
evokes accumulation of Smac56 in 911 cells, because UPS
efficiently destabilizes Smac56 protein in the cells (Burke and
Smith, unpublished data). Possibly some of the nascent Smac56
that is produced during the treatment with the proteasome
inhibitor can interact with IAPs and accounts for the minor pull
down of Apollon, cIAP1, cIAP2, and XIAP (Fig. 8).
Discussion
Our results indicate that cytosolic localization of mature Smac
can subject it to a novel downregulatory mechanism in 911 line of
human embryonic retinoblasts. We have shown that persistent
cytosolic expression attenuated the ability of wild type Smac56 to
oligomerize and to interact with IAPs (Figs. 5 to 8). It is known that
dimerization defective mutants of Smac fail to interact with BIR2
of XIAP in vitro and have a reduced capacity to antagonize XIAP
[6]. Interestingly, stably expressed Smac60 retained the ability to
dimerize and to interact with IAPs (Figs. 5 to 7). The A
60QKS
63
residues at the N-terminus of Smac60 may serve as a ‘‘secondary’’
IBM that binds full-length XIAP, as previously suggested [6].
Perhaps the ‘‘secondary’’ IBM accounts in part for the retention of
a tenacious interaction between Smac60 and XIAP because the
initial Ala of the IBM is critical for IAP binding [6,19,40]. It is
noteworthy that Smac has a second interaction interface that binds
the BIR3 domain of XIAP, which consists of hydrogen bonds and
van der Waals interactions and is more than twice the surface area
of the IBM-binding interface [7]. Thus, it is not surprising that
Smac60 retains the capacity to interact with XIAP in vitro [6] and
intracellularly (Fig. 1B and 5B). Our Smac60 findings agree well
with the study of Smacb, which showed that the IBM is not
required for interaction with XIAP and cIAPs [3,15].
The Smac dimer is highly stable in vitro with a dissociation
constant (Kd)o f3 4 610
221 M [11], which may preclude monomer
exchange with dimeric Smac. We have found that ectopic
Smac56, which was produced in mitochondria from full-length
Smac
1-239, failed to interact with cytosolic Smac56 produced by
Ub fusion (Fig. 2). Therefore, cytosolic ectopic Smac56 or Smac60
is unlikely to heterodimerize with endogenous mitochondrial Smac
and form a hybrid proapoptotic protein. The extraordinary
stability of the Smac dimer supports the idea that the
posttranslational modification(s) that attenuates dimerization
specifically targets a critical regulatory motif.
Stably expressed cytosolic Smac60, which lacks the IBM and has
a weakened ability to antagonize XIAP in vitro [6], retained the
capacitytocomplexwithXIAP,andtopotentiatecaspaseactivation
andapoptosisin911cells(Figs.3to5).Ironically,thepotentiationof
caspase activation was much greater for Smac60 than for Smac56
(Fig. 3). Furthermore, the proapoptotic function of Smac60 (Figs. 3
and 4) is probably produced by cytosolic homodimeric Smac60, not
a heterodimer of Smac60 with endogenous wild type Smac, because
we were unable to detect dimerization of cytosolic ectopic Smac56
with mitochondrial Smac56 (Fig. 2). However, the release of
endogenous dimeric mitochondrial Smac to the cytosol following
proteasome inhibition may contribute to the proapoptotic function
of Smac60. The proapoptotic function of Smac60 agrees with the
previous report that neither the IBM of Smac, nor the neighboring
amino-terminal segment, isrequiredfora proapoptoticfunction[3].
However, Hunter et al. reported that cytosolic Smac60 failed to
potentiate the induction of apoptosis by etoposide in HeLa cells
[39]. We have confirmed this finding in 911 cells (Burke and Smith,
unpublisheddata), which indicatesthat the potentiationof apoptosis
by Smac60 depends on the agent used to induce apoptosis.
We have found that the disarming mechanism that monomer-
ized cytosolic Smac56 failed to inactivate Smac60 (Figs. 3 and 5),
which indicates that the disarming mechanism depended on the
IBM, i.e., the first four amino acids of mature Smac. Presumably a
posttranslational modification of one or more residues of the dimer
interface near the IBM monomerized Smac. Additionally the
disarming mechanism depended on the cellular location of Smac,
not on the abundance of ectopic Smac, because the level of
cytosolic ectopic Smac was substantially lower than that of
endogenous mitochondrial Smac (Fig. 7A). Thus, the disarming
mechanism acts on relatively low abundance expression of
cytosolic ectopic Smac. Furthermore, the disarming mechanism
prefers dimeric to monomeric Smac as discussed below. Studies of
a dimer interface mutant support the conclusion that persistent
cytosolic expression disables mature Smac dimerization. Stably
expressed cytosolic Smac56 comigrated by native PAGE with the
F88DSmac56 mutant that is dimerization defective (Fig. 6). By
contrast, transiently expressed Smac56 migrated as a doublet of
oligomeric bands during native PAGE, similarly to transiently or
stably expressed Smac60. Interestingly, we recently observed that
endogenous Smac of 911 cells and other human cell lines, which
migrates as a single band by SDS-PAGE, migrates as three bands
by native PAGE, which correspond in mobility to the monomeric
and two oligomeric species of ectopic Smac56 (Burke and Smith,
unpublished data). Denaturation of wild type or mutant Smac by 8
M urea or by SDS gave one major Smac species (Figs. 6 and 7).
Therefore, the two Smac bands observed by native PAGE differ in
Figure 4. Persistent cytosolic expression of Smac56 or Smac60
potentiates apoptosis and cell death evoked by zIEALal. Cell
lines that stably expressed the indicated Smac variant (3 independent
clones transfected with empty vector (IRES2.eGFP) (Mock) or with the
indicated Smac variant) were incubated with or without zIEALal for
24 h. Following the treatment, both floating and attached cells were
harvested and stained with annexin V-PE and 7-AAD, and analyzed by
FACS. Apoptotic cells positively stained for annexin V-PE only, and
dying cells were positively stained for 7-AAD only or for 7-AAD and
annexin V-PE. Values are mean 6 S.E.M (n=9). Two-way Anova followed
by the Bonferroni post-test gave the indicated p values (***,0.001)
(Prism, Graphpad Software).
doi:10.1371/journal.pone.0013094.g004
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Because proteins migrate as a concentrated band by native PAGE,
it seems to have greater potential than gel filtration chromatog-
raphy to detect an additional oligomeric species besides the dimer.
The loss of immunoreactivity of wild type and mutant Smac
provided further support for the conclusion that the Smac
monomerization involves a posttranslational modification of an
amino acid(s) at or near the dimer interface. Thus, certain
missense mutations in the dimer interface (V78E, V81D, and
F88D) abolished immunostaining by a monoclonal antibody
(Fig. 7). Smac monomerization per se did not destroy the epitope
because the monomeric L163D mutant was recognized by the
antibody (Fig. 7B). Furthermore, the retention of immunoreactiv-
ity of the stably expressed L163D mutant suggests that the
disarming mechanism prefers dimeric to monomeric Smac.
Importantly, transiently expressed wild type Smac56, like
transiently or stably expressed Smac60, have an intact epitope
(Fig. 7). The segment of the dimer interface that affected epitope
recognition (amino acids 78 to 94) has 10 phosphorylatable
residues. Addition of a phosphate moiety, like substitution of a
hydrophobic residue by an aspartate or glutamate, would be
expected to similarly affect recognition by the Smac antibody.
Recently Park et al. reported that recombinant Smac can be
phosphorylated by JNK3 in vitro [41]. Although the stoichiometry
of Smac phosphorylation was not reported, phosphorylation
decreased Smac interaction with XIAP similarly to our results
with Smac56 following persistent cytosolic expression. While we
readily detected ubiquitinated Smac56 species following transient
cotransfection of Smac56 and XIAP (Fig. 1B), no ubiquitinated
Smac56 in cell lines that stably express Smac56 alone was detected
(Burke and Smith, unpublished data). We favor the possibility of
phosphorylation at or near the dimer interface, which would have
Figure 5. Persistent cytosolic expression of Smac56, but not Smac60, ablates dimerization and interaction with XIAP. (A) Cells that
stably expressed the indicated Ub-Smac-V5 plasmid (IRES2.eGFP) were transiently transfected with the Ub-Smac-GST plasmids (pGFLEX), lysed, and
proteins were purified using GSH-agarose. Lysate proteins (Input) and proteins eluted from the GSH-agarose (Pulldown) were resolved by SDS-PAGE
and subjected to western blot analysis with antibody to GST-pi and the V5 epitope. (B) Cells that stably expressed the indicated Ub-Smac-V5 plasmid
(IRES2.eGFP) were transiently transfected with GST-XIAP plasmid (pGFLEX), lysed, and Input and Pulldown proteins were resolved by SDS-PAGE and
subjected to western blot analysis with antibody to XIAP and the V5 epitope as described for (A).
doi:10.1371/journal.pone.0013094.g005
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observed (Fig. 5 to 7). However, posttranslational modification(s)
other than, or in addition to phosphorylation, are not excluded by
the present data. An important future achievement will be to
identify the posttranslational modification(s) that monomerizes
Smac and destroys the epitope recognized by the monoclonal
antibody and the enzyme(s) involved.
Curiously, we observed that stably expressed ectopic Smac56,
which failed to interact with IAPs (Fig. 8) or to markedly potentiate
caspase activation following proteasome inhibition in 911 cells
(Fig. 3), potentiated the induction of apoptosis (Fig. 4). Monomeric
Smac56 may serve a failsafe proapoptotic function, which is not
subject to downregulation via the Ub ligase E3 of IAPs.
Furthermore, the proapoptotic function of monomeric Smac56
appears to be independent of IAP antagonism and may not be
mediated by caspase activation (Fig. 3C). Because proteasome
inhibition slightly increased the level of cytosolic Smac56 that
interacted with IAPs (Fig. 8), it is possible that some of the
potentiation of apoptosis by Smac56 is due to the canonical IAP
antagonism. However, recent studies of dimerization defective
Smac mutants indicate that they retain a proapoptotic function
that appears to be independent of IAP antagonism (Burke and
Smith, unpublished data).
Stably expressed cytosolic Smacd, which has the IBM but lacks
amino acids 62–105, retained the capacity to homodimerize and
interact with XIAP as previously reported [4], but failed to
heterodimerize with wild type Smac or to potentiate caspase
activation or apoptosis (Figs. 2 to 5). Hence, residues 62–105 of
wild type Smac may prevent heterodimerization with Smacd.
Because Smacd homodimerized (Fig. 5), it was not subject to the
same disarming mechanism as wild type Smac. The Smacd results
agree with the Smac antibody data discussed above that indicate
the disarming mechanism acts on wild type dimer interface
residues (78 to 94) that Smacd lacks. Stably expressed cytosolic
Smacd failed to potentiate induction of apoptosis evoked by
proteasome inhibition, although it modestly increased caspase
activation (Figs. 3 and 4). Fu et al. found that transiently expressed
mitochondrial Smacd potentiates apoptosis by chemotherapeutic
agents, apparently by decreasing the level of XIAP protein via
UPS [4]. Proteasome inhibibition would prevent destabilization of
XIAP protein by Smacd, which may explain the lack of
potentiation of apoptosis following proteasome inhibition (Fig. 4).
Our results suggest that neither cytosolic Smacb, which lacks an
IBM, nor Smacd, which homodimerized after stable cytosolic
expression (Fig. 5), are subject to the downregulation described
here for wild type Smac56. The insensitivity of Smacb and Smacd
to the monomerizing downregulatory mechanism distinguishes
their proapoptotic function from that of wild type Smac.
In summary, the present study uncovered a novel mechanism
which can downregulate cytosolic mature Smac. The putative
posttranslational modification(s) depended on the presence of the
IBM of mature dimeric Smac and occurred at or near the dimer
interface.
Materials and Methods
Cell culture and transfection
The 911 line of immortalized human embryonic retinoblasts
was grown in a 1:1 mixture of Dulbecco’s modified Eagle’s
medium/Ham’s F-12 containing 10% (v/v) fetal bovine serum
(FBS) [42]. The cells were plated (6610
5 per 35 mm dia. tissue
culture dish), incubated for 6 h in a humidified atmosphere
containing 5% CO2-95% air, and transfected with a modified
calcium phosphate method as described [43]. After 16 h, the cells
were rinsed with PBS, and refed.
Two days after transfection, the cells were refed with growth
medium containing 0.3 mg/ml G418. Two weeks later, green
fluorescent protein (GFP) positive cells were sorted and collected
with a fluorescent activated cell sorter (FACS). The cells were
plated at a low density (100 cells/100 mm dia. culture) to isolate
individual colonies. At least three clones were isolated and used in
each of the experiments described here. Stably transfected cell
lines were always grown in medium containing 0.3 mg/ml G418.
Western blot analysis
Whole cell lysates were prepared as described for the GST
pulldown experiments (see below), and protein concentrations
were determined using a Bradford reagent (BioRad). Lysate
proteins (20 to 40 mg) were size fractionated by SDS-PAGE.
Proteins were electrophoretically transferred to a PVDF mem-
brane and immunostained with antibodies to: the V5 epitope tag
(Invitrogen), XIAP (BD Transduction Labs, 610717), GST-p (GS-
72, Oxford Biomedical Research, FLAG tag (F9291, Sigma
Aldrich), Smac (05-681, Millipore), b-tubulin (T6199, Sigma
Aldrich), cleaved PARP (No. 9541, Cell signaling technology), or
intact PARP (SA-249, Biomol). Immunostaining was detected with
the LumiGLO (Kirkegaard & Perry Laboratories). Exposed X-ray
film (B Plus blue, Medlink Imaging) was scanned with an Epson
Precision 4870 Photo scanner. Western blots are representative of
at least 3 independent experiments.
Subcellular fractionation
911 cells were plated (4.4610
6 per 100 mm dia. culture dish)
and transfected with IRES2.eGFP empty vector, or vector
Figure 6. Native and urea PAGE of Smac56, Smac60, and the
dimer interface F88D mutant of Smac56. Cell lines that stably
expressed the indicated Ub-Smac-V5 (IRES2.eGFP) and cells that were
transiently transfected with Ub-Smac56-V5 or Ub-Smac60-V5 (IRE-
S2.eGFP) were lysed, and proteins were resolved by native PAGE or
by PAGE in the presence of 8 M urea as indicated. Western analysis was
done with antibody to the V5 epitope.
doi:10.1371/journal.pone.0013094.g006
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calcium phosphate method [43]. Approximately 34 h after
transfection, 10 mg/ml cycloheximide was added to the culture
media. Six h later the cultures were washed twice with ice-cold
PBS, and the cells were detached using a rubber scraper. The cells
were collected by centrifugation at 7506g for 5 min at 4uC and
resuspended in an equal volume of buffer containing (in mM) 250
sucrose, 20 Hepes-Tris, pH 7.5, 10 KCl, 1.5 MgCl2, 1 EDTA, 1
EGTA, 1 dithiothreitol (DTT), and 10 mg/ml each of leupeptin
and aprotinin. After a 15 min incubation on ice, the cells were
disrupted with a micropipet. Unbroken cells were removed by
centrifugation at 7506g for 10 min at 4uC. The mitochondrial
pellet was produced by centrifugation at 10,0006g for 15 min at
4uC. The supernatant was centrifuged at 100,0006g for 1 h at
4uC to obtain the cytosolic fraction.
Pulldown of GST-protein complexes from cell lysates
Cultures were rinsed with ice cold PBS and lysed in a buffer
containing 20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.2% NP-
40, 5 mM DTT, 10 mg/ml leupeptin, 10 mg/ml aprotinin,
0.1 mM sodium orthovanadate, and 80 mM benzamidine. Cells
were homogenized by passage through a 26-gauge needle and
centrifuged 16,0006ga t4 uC for 10 min to remove unbroken cells.
The protein concentration of the supernatant was determined with
a Bradford reagent (BioRad) using bovine serum albumin (BSA) as
a standard. Lysates (0.12 mg protein) were diluted to 1 ml with
lysis buffer containing a 25 ml glutathione (GSH)-agarose equili-
brated in 20 mM Tris-HCl, pH 7.4, 2 mM MgCl2, 1 mM DTT,
and protease inhibitors (see above). Lysates were incubated with
GSH-agarose for 16 h at 4uC with rotation at 20 rpm. The
agarose was washed five times with 1 ml GSH-agarose equilibra-
tion buffer. Proteins were eluted with SDS sample loading buffer
and resolved by SDS-PAGE.
Caspase-3-like activity
Cell lines that were stably tansfected with empty vector or Ub-
Smac were grown in 35 mm dia. culture dishes, which were
inoculated with 5610
5 cells. The following day the medium was
removed and replaced with culture media with or without 20 mM
benzoyloxy-Ile-Glu-Ala-leucinal (zIEALal), and 18 h later at-
Figure 7. Persistent cytosolic expression of Smac56, but not Smac60, ablates immunostaining by a monoclonal antibody similarly
to certain missense mutations of the dimer interface. (A) Cell lines that stably expressed the indicated Ub-Smac-V5 plasmids (IRES2.eGFP) and
cells that were transiently transfected with Ub-Smac56-V5 or Ub-Smac60-V5 (IRES2.eGFP) were lysed and proteins were resolved by SDS-PAGE. Mock
indicates a cell line transfected with empty IRES2.eGFP vector. Western blot analysis was done firstly with the monoclonal Smac antibody and
secondly with antibody to the V5 epitope. (B) Cell lines that stably expressed the indicated missense mutation of Ub-Smac56-V5 (IRES2.eGFP) and
cells that were transiently transfected with Ub-Smac56-V5 (IRES2.eGFP) were lysed, and proteins were resolved by SDS-PAGE. Western blot analysis
was done as indicated for (A).
doi:10.1371/journal.pone.0013094.g007
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medium. Cell suspensions were centrifuged at 1856g for 5 min.
The cells were washed twice with ice cold PBS and collected by
centrifugation at 16,0006g for 30 sec. The cells were suspended
with a buffer containing 20 mM Tris-HCl, pH 8.0, 1 mM EGTA,
1 mM DTT, and 10 mg/ml leupeptin, aprotinin, and pepstatin.
The cells were disrupted by five freeze/thaw cycles using liquid
nitrogen and a room termperature water bath. Lysates were
clarified by centrifugation at 16,0006g for 10 min at 4uC. The
protein concentration of the clarified lysate was determined with a
Bradford reagent (BioRad) and BSA as standard. Caspase activity
of a 75 mg sample of lysate was assayed with 50 mM acetyl-Asp-
Glu-Val-Asp-7-amino-4-methyl coumarin (Ac-DEVD-amc) as
substrate. Fluorescence caused by the production of amc was
continuously recorded at 440 nm (excitation at 380 nm) at 37uC
in 2 ml of buffer containing 20 mM Tris-HCl, pH 8.0, and 2 mM
MgCl2.
Flow cytometry analysis of apoptosis and cell death
Stably transfected cells were plated at 1.2610
6 cells per 60 mm
dia. culture dish. The following day the cultures were refed with
fresh growth medium with or without 20 mM zIEALal, a peptidyl
proteasome inhibitor. Twenty-four hours later the floating and
attached cells were scraped into the growth medium and harvested
by centrifugation at 1856g for 5 min at room temperature. The
cells were washed once with ice cold PBS, suspended with 0.05%
trypsin in PBS, and incubated for 5 min at room temperature. The
trypsin reaction was stopped by addition of 1 ml growth medium
containing 10% FBS. Cells were centrifuged at 2,3006g for 30 s at
room temperature and washed twice with Annexin V-PE binding
buffer: 10 mM Hepes/NaOH, pH 7.4, 140 mM NaCl, 2.5 mM
CaCl2. The cells were suspended in 1 ml of the binding buffer and
5 ml Annexin V-PE (BD Pharmingen) and 5 ml 7-amino-actinomy-
cin D (7-AAD) viability staining solution (eBioscience) were added.
The cells were incubated at room temperature in the dark for
Figure 8. Persistent cytosolic expression of Smac56 attenuates its interaction with Apollon and cIAPs. Cells indicated by a T (Transient)
were cotransfected with Ub-Smac56-V5 (IRES2.eGFP), whereas those indicated by a S (Stable) stably expressed Ub-Smac56-V5 (IRES2.eGFP).
Additional cultures were transiently transfected with the indicated FLAG-IAP (p3XFLAG.CMV10). The cells that stably expressed Ub-Smac56-V5 were
treated for 12 h with 20 mM zIEALal to increase the level of Smac56, which is rapidly degraded by UPS (Burke and Smith, unpublished data). Cell
pellets from each IAP transfection were combined with a pellet of cells that were transiently or stably transfected with Ub-Smac56. The combined cell
pellets were lysed, and proteins were immunoprecipitated with a polyclonal antibody to the V5 epitope. Lysate proteins (Input) and proteins eluted
from the immune complex (Immunoprecipitate) were resolved by SDS-PAGE and subjected to western blot analysis with monoclonal antibody to the
V5 or FLAG epitope.
doi:10.1371/journal.pone.0013094.g008
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binding buffer. The cell suspensions were filtered using cell-strainer
cap tubes (Falcon 352235) and analyzed within 1 h of beginning the
incubation with Annexin V-PE using a BD LSR II FACS.
Native and urea PAGE
For native electrophoresis, polyacrylamide gels (10%) were
prepared as described by Sambrook et.al [44] except SDS was
omitted from the gel, the sample loading buffer, and the running
buffer. Similarly, 10% gels (1 mm thick) containing 8 M urea were
prepared and proteins electrophoresed without SDS using the
mini-PROTEAN 3 system (Bio-Rad). Lysate proteins (5 to 20 mg)
from cells stably or transiently transfected with wild type or a Smac
variant were resolved on the gels to normalize ectopic protein
levels. Lysates were loaded onto native gels with an 8 times
concentrated loading buffer: 400 mM Tris HCl, pH 6.8, 5.7 M b-
mercaptoethanol, 80% glycerol, and 0.05% bromophenol blue.
Lysates for urea gels were incubated at 4uC for 1 h with 2 times
concentrated loading buffer; 8 M urea, 50 mM Tris-HCl, pH 6.8,
715 mM b-mercaptoethanol, and 0.006% bromophenol blue,
prior to electrophoresis. Samples for both gel types were loaded
without boiling, to reduce the possibility of protein aggregation.
Gels were run at a constant 175 V for 90 min at 4uC in a buffer
containing 25 mM Tris and 192 mM glycine buffer. Proteins were
transferred to a PVDF membrane with the usual SDS transfer
buffer, and western analysis was performed.
Co-immunoprecipitation of IAPs with Smac56-V5
911 cells (6610
5 cells per 35 mm dia. dish) were transiently
transfected with IRES2.eGFP Ub-Smac56 or p3XFLAG.IAP
plasmids. The following day transiently transfected cultures were
refed with fresh growth media, and cultures of stably transfected
IRES2.eGFP Ub-Smac56-V5 cells were plated (8610
5 cells per
35 mm dia. dish) and allowed to incubate for 12 h before refeeding
with medium containing 20 mM zIEALal. The stably and
transiently transfected cultures were washed twice with ice-cold
PBS, and the cells were scraped from the dishes in PBS. Cell
suspensions containing each of the transiently transfected FLAG-
IAP cells were combined with cells that transiently or stably
expressed Smac56. The combined cell suspensions were centrifuged
at 16,0006g for 15 s at 4uC, and the cells were lysed in
immunoprecipitation buffer containing 150 mM NaCl, 20 mM
Tris-HCl, pH 7.5, 0.2% NP-40, 3 mM MgCl2, 1 mM EDTA,
1 mM EGTA, 10 mg/ml each of leupeptin and aprotinin, 0.1 mM
sodium orthovanadate, 80 mM benzamidine, and 100 mM pefabloc
SC. A sample of each lysate (30 mg) was subjected to western blot
analysis, and the remainder of each lysate was diluted to 1 ml with
lysis buffer, and 0.3 mg of a polyclonal V5 antibody (AB3792,
Millipore) was added. After 2 h at 4uC, 10 ml of buffer equilibrated
protein A/G plus agarose (Sc-2003, Santa Cruz) was added and the
incubationcontinuedfor1 h.Theprotein A/Gagarose waswashed
3 times with 1 ml lysis buffer, and immunoprecipitated proteins
were eluted with SDS sample loading and subjected to western blot
analysis with monoclonal antibodies to the FLAG and V5 epitopes.
Ub-Smac fusion constructs
Total RNA was prepared from HeLa cells using Trizol reagent
(Gibco BRL) according to the instructions of the manufacturer.
Total RNA (1 mg) was incubated with 10 pmole Smac reverse
primer (see Table 1 for all primer sequences) in a total volume of
14 mla t7 0 uC for 5 min. The reaction was immediately placed on
ice and the following were added: 1 ml RNAse Inhibitor
(Eppendorf), 5 ml MMLV RT buffer, 1 ml MMLV RT (200
units/ml) (Promega), and 4 ml 10 mM dNTPs. The reaction was
incubated at 42uC for 1 h, followed by 15 min at 70uC. A sample
(2 ml) of the reaction was used to amplify full-length Smac using
the full-length Smac forward primer and the Smac reverse primer
with the following PCR cycling conditions: 94uC for 1 min;
followed by 30 cycles of 94uC for 30 s, 65uC for 30 s, and 72uC for
2 min; and finally 72uC for 5 min. The PCR product was cloned
into pCRBLUNT (Invitrogen).
A pcDNA3.1 plasmid (Invitrogen) encoding Ub with an amino-
terminal hemagglutinin (HA) tag was used as a template to amplify
HA-Ub [43]. The full-length Smac1-239 cDNA was excised from
pCRBLUNT using Hind III and Not I, and subcloned into
pcDNA3.1/V5-His B. HA-Ub-Smac cDNA was generated by
two-step overlap extension. The first step consisted of two
reactions to amplify HA-Ub and full-length Smac separately using
the following cycle conditions: 94uC for 1 min; 30 cycles of 94uC
for 30 s, 65uC for 30 s, and 72uC for 2 min; and 72uC for 5 min.
In the second step, a sample (2 ml) of the PCR products from each
reaction was mixed and reamplified: 94uC 1 min; 25 cycles of
94uC for 30 s, 65uC for 30 s, 72uC for 2 min; and 72uC for 5 min.
The final products were digested with Hind III and Not I, purified
with QIAquick PCR purification kit (Qiagen), and ligated into
pcDNA3.1/V5-HisB. The HA-Ub forward and the Smac reverse
primers were used for all second step reactions. The following
overlap extension primers were used: Ub-Smac overlap forward
primer, and Ub-Smac overlap reverse primer. A plasmid encoding
HA-Ub-Smac1-239 was used as a template to generate the HA-
Ub-Smac56-239 and HA-Ub-Smac60 fusions by overlap exten-
sion PCR using Ub-Smac56-239 forward and reverse primers and
HA-Ub-Smac60 forward and reverse primers, respectively. The
HA-Ub-Smac56-239 plasmid was used as a template to generate
HA-Ub-Smacd by overlap extension PCR using HA-Ub-Smacd
forward and reverse primers. Smac56 and G76VUb-Smac56
point mutants were generated by the QuikChange method
(Stratagene) with the protocol suggested by the manufacturer.
The following pairs of forward and reverse primers were used to
produce the indicated amino acid substitutions: V78E; V81D;
F88D; L163D; and UbG76V. The pcDNA3.1 expression plasmids
were used as templates to PCR amplify and subclone the Ub-Smac
inserts lacking the HA and His tags into IRES2.eGFP (Clontech)
after BamHI digestion. The following primers were used: Ub
forward BamHI and V5 reverse BamHI. Ub-Smac56 and Ub-
Smacd were cloned in frame with a C-terminal glutathione
sulfotransferase (GST) tag in pGFLEX (ATCC 87629) after PCR
amplification with the following primers: Ub-forward ClaI, and
Smac reverse ClaI. The PCR product and the pGFLEX plasmid
were digested with ClaI. The digested plasmid was dephosphor-
ylated and ligated with the PCR product. Clones with the insert in
the forward orientation were identified by nucleotide sequence
analysis. All cDNA inserts were validated by complete nucleotide
sequence analysis.
Gateway cloning of IAPs into destination vectors
A CMV10 expression plasmid with a 3xFLAG-tagged Apollon
insert was generously provided by M. Naito [29]. Plasmids
containing cDNA inserts of cIAP1 (MGC-26517), cIAP2
(10436078), Survivin (MGC-8592), and Livin (10659534) were
purchased from ATCC. A pGFLEX-XIAP plasmid was produced
as described below. The plasmids were used as templates to
amplify and subclone the IAPs into the pENTR/D-TOPO
plasmid (Invitrogen). The following forward and reverse primer
pairs were used in the PCR reactions: cIAP1; cIAP2; Livin alpha;
Survivin; and XIAP. Plasmids containing the appropriate insert
were identified after restriction endonuclease digestion and
confirmation of the nucleotide sequence. A gateway compatible
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Eco RV digestion and in frame ligation of a recombination site,
using the Gateway vector conversion system (Invitrogen) according
the manufacture’s protocol. The pENTR/D-TOPO (Invitrogen)
plasmids containing IAPs were mixed with a p3xFLAG destination
plasmid or the pDEST-15 plasmid (Invitrogen) for bacterial
production of GST-IAPs. Recombinant plasmids were produced
by incubation in a reaction containing LR Clonase II. Proper
recombination was confirmed by PCR amplification with gene
specific primers for each IAP. All cDNA inserts were validated by
complete nucleotide sequence analysis.
Cloning of XIAP into GST expression plasmids
pcDNA3.1/GS XIAP (Invitrogen) was used a template to PCR
amplify XIAP with forward and reverse XIAP primers primer
with the following PCR cycling conditions: 94uC for 1 min;
Table 1. Primers used for cloning and overlap extension.
Smac cloning and Overlap extension primers
Primer name Primer sequence
Smac reverse TTTGCGGCCGCCATCCTCACGCAGGTAGG CCTCCTGCTC
Full-length Smac forward CCCAAGCTTGCAATGGCG GCTCTGAAGAGTTGGGCTGTCG
HA-Ub forward GGGAAGCTTGCAAT GGCTAGCTACCCTTATGACGTCCCCG
Ub-Smac overlap forward GTCTCAGAGGTGGGATGGCGGCTCTGAAGAGTTGGCTGTC
Ub-Smac overlap reverse TTCAGAGCCGCCATCCCACCTCTGAGACGGAGGACCAGGT
Ub-56-239 forward CGTCTCAGAGGTGGGGCGGTTCCTATTGCACAGAAATCAGAG
Ub-56-239 reverse TGCAATAGGAACCGCCCCACCTCTGAGAC GGAGGACCAGGT
Ub-60-239 forward CGTCTCAGAGGTGGGGCACAGAAATCAG AGCCTCATTCCCTT
Ub-60-239 reverse CTCTGATTTCTGTGCCCACCTCTGAGACGG AGACGGAGG ACCAGGT
Smacd forward CGGTTCCTATTGCACAGGCTGTTTATACCTTAACTTCTCTTTACCG
Smacd reverse TAAGGTATAAACAGCCTGTG CAATAGGAACCGCCCCACCTCT
Ub forward BamHI GGCGAATAGGATCCAGAGGCATGCAGATCTTCGTGAAG
V5 reverse Bam HI GGCTTAGTGGATCCTTAACGCGTAGAATCGAGACCGA
Ub forward ClaI GAATTCATCGATGCAGATCTTCGTGAAGACCCTGACTGG
Smac reverse ClaI GAATTCATCGATGAATCCTCACGCAGGTAGGCCTC
pGFLEX XIAP
XIAP forward GCGAGCGGCCGCATATGACTTTTAACAGTTTTGAAGGAT
XIAP reverse GGGGAGCGGCCGCTAATTAAGACATAAAAATTTTTGC
Mutagenesis primers
Smac V78E forward GTGAAGCATTGATGAGGAGAGC AGAGTCTTTGGTAACAG
Smac V78E reverse GAGGTGCTATCTGTTACCAAAGACTCTGCTCTCCTCATC
Smac V81D forward GATGAGGAGAGCAGTGTCTTTGGACACAGATAGCACCTC
Smac V81D reverse GAGAAAGGTAGAGGTGCTATCTGTGTCCAAAGACACTGC
Smac F88D forward ACAGATAGCACCTCTACCGACCTCTCTCAGACCACATATGCG
Smac F88D reverse CGCATATGTGGTCTGAGAGAGGTCGGTAGAGGTGCTATCTGT
Smac L163D forward CTTGGATGACTGCAGTTGGTGACTCAGAGATGGCAGCAGAAG
Smac L163D reverse GCAGCTTCTGCTGCCATCTCTGAGTCACCAACTGCAGTCATCC
Ub G76V forward GTCCTTCGTCTCAGAGGTGTGGCGGTTCCTATTCACAG
Ub G76V reverse CTGTGCAATAGGAACCGCCACACCTCTGAGACGAAGGAC
3xFLAG IAP primers
cIAP1 forward CACCATGCACAAACCTGCCTCCCAAAGAC
cIAP1 reverse TCATTAAGAGAGAAATGTACGAACAG
cIAP2 forward CACCATTGAACATAGTAGAAAACAGC
cIAP2 reverse TCATCATGAAAGAAATGTACGAACTGTACC
Livin forward CACCATGGGACCTAAAGACAGTGCC
Livin reverse TCACTAGGACAGGAAGGTGCGCACGCG
Survivin forward CACCATGGGTGCCCCGACGTTGCCC
Survivin reverse TCATCAATCCATGGCAGCCAGCTGCTC
XIAP forward CACCATGACTTTTAAGAGTTTTGAAG
XIAP reverse TTATTAAGACATAAAAATTTTTTGCTTG
doi:10.1371/journal.pone.0013094.t001
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2 min; and finally 72uC for 5 min. The product was ligated into
pCRBLUNT, excised with Not I and subcloned into pGFLEX.
The pGFLEX.XIAP expression plasmid was used for mammalian
expression of GST-XIAP.
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